SCHEMBL5555769

SCHEMBL5555769

NC(=O)Nc1sc(-c2ccc(Cl)cc2)nc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.49
RAB9A P51151 4/20 0.49
NPC1 O15118 4/20 0.49
POLB P06746 2/20 0.49
TBK1 Q9UHD2 8/20 0.46
GAA P10253 2/20 0.45
XDH P47989 1/20 0.44
IKBKE Q14164 6/20 0.43
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 3/20 0.41
PTGDR2 Q9Y5Y4 2/20 0.41
HPGD P15428 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556366 0.87 TBK1 (0.55) KDM4ESMN1; SMN2TBK1GAAIKBKE
SCHEMBL5555722 0.86 MEN1 (0.49) SMN1; SMN2TBK1IKBKEALDH1A1KMT2A
SCHEMBL5554758 0.86 TBK1 (0.56) KDM4ERAB9ATBK1GAAIKBKE
SCHEMBL5554860 0.83 CHEK1 (0.52) KDM4ESMN1; SMN2RAB9ANPC1TBK1
SCHEMBL6015302 0.82 CHEK1 (0.49) KDM4ETBK1KMT2AMAPTATM
SCHEMBL2524367 0.80 KDM4E (0.48) KDM4ESMN1; SMN2RAB9ANPC1POLB
SCHEMBL5192550 0.78 KDM4E (0.55) KDM4ESMN1; SMN2RAB9ANPC1POLB
SCHEMBL6496085 0.75 KDM4E (0.63) KDM4ESMN1; SMN2RAB9ANPC1POLB
SCHEMBL1564481 0.74 CHEK1 (0.67)
SCHEMBL5555715 0.74 PIN1 (0.47) TBK1XDHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors ASTRAZENECA AB (SE) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors CHEK1, CHKA, CHEK2 KDM4E 713/4885SMN1; SMN2 4643/4885RAB9A 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.